
Metformin (500mg) + Glimepiride (2mg)
Rayax Drug India
Glimepiride 2mgPack Size
Strip of 10 tablets
Price
Save ₹209
that's 85% off!
Active composition
+1 more active ingredient
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Metsmall G 2mg/500mg Tablet is a fixed-dose combination of glimepiride (2mg) and metformin (500mg) indicated for the treatment of type 2 diabetes mellitus. Glimepiride, a sulfonylurea, stimulates insulin secretion and improves glucose tolerance, while metformin, a biguanide, reduces glucose production in the liver and increases glucose uptake in the peripheral tissues. The tablet is available in a single dose strength of 2mg/500mg and is administered orally once or twice daily, depending on patient response and tolerability. In clinical trials, Metsmall G 2mg/500mg Tablet demonstrated significant improvements in glycemic control, with median reductions in HbA1c of 1.3% to 1.5% compared to baseline values. The most common adverse reactions were hypoglycemia, nausea, vomiting, and diarrhea. Metsmall G 2mg/500mg Tablet should be used with caution in patients with renal impairment, heart failure, or a history of serious hypersensitivity reactions to sulfonylureas or biguanides. As with all antidiabetic medications, it is essential to monitor patient blood glucose levels and adjust therapy as necessary to prevent hypoglycemia.
How to use Metsmall G Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Metsmall G 2mg/500mg Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Metsmall G 2mg/500mg Tablet.
High Risk
Metsmall G 2mg/500mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Metsmall G 2mg/500mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Metsmall G 2mg/500mg Tablet may be needed. Please consult your doctor. Metsmall G 2mg/500mg Tablet is generally started with a low dose in patients with mild to moderate liver disease, and its use is not recommended in patients with severe liver disease.
Regular Checkup
Metsmall G 2mg/500mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Metsmall G 2mg/500mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Metsmall G 2mg/500mg Tablet may be needed. Please consult your doctor. Use of Metsmall G 2mg/500mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function tests is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Metsmall G 2mg/500mg Tablet

Glimepiride (2mg) + Metformin (500mg)
Rayax Drug India
Glimepiride 2mgPack Size
Strip of 10 tablets
Price
Save ₹209
that's 85% off!
Active composition
+1 more active ingredient
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Metsmall G 2mg/500mg Tablet is a fixed-dose combination of glimepiride (2mg) and metformin (500mg) indicated for the treatment of type 2 diabetes mellitus. Glimepiride, a sulfonylurea, stimulates insulin secretion and improves glucose tolerance, while metformin, a biguanide, reduces glucose production in the liver and increases glucose uptake in the peripheral tissues. The tablet is available in a single dose strength of 2mg/500mg and is administered orally once or twice daily, depending on patient response and tolerability. In clinical trials, Metsmall G 2mg/500mg Tablet demonstrated significant improvements in glycemic control, with median reductions in HbA1c of 1.3% to 1.5% compared to baseline values. The most common adverse reactions were hypoglycemia, nausea, vomiting, and diarrhea. Metsmall G 2mg/500mg Tablet should be used with caution in patients with renal impairment, heart failure, or a history of serious hypersensitivity reactions to sulfonylureas or biguanides. As with all antidiabetic medications, it is essential to monitor patient blood glucose levels and adjust therapy as necessary to prevent hypoglycemia.
How to use Metsmall G Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Metsmall G 2mg/500mg Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Metsmall G 2mg/500mg Tablet.
High Risk
Metsmall G 2mg/500mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Metsmall G 2mg/500mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Metsmall G 2mg/500mg Tablet may be needed. Please consult your doctor. Metsmall G 2mg/500mg Tablet is generally started with a low dose in patients with mild to moderate liver disease, and its use is not recommended in patients with severe liver disease.
Regular Checkup
Metsmall G 2mg/500mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Metsmall G 2mg/500mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Metsmall G 2mg/500mg Tablet may be needed. Please consult your doctor. Use of Metsmall G 2mg/500mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function tests is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Metsmall G 2mg/500mg Tablet













